EUTROPICS PHARMACEUTICALS, INC.
CAMBRIDGE, MA · CIK 0001892756 · Medtech
PraediCare Dx™, a clinical diagnostic assay that predicts patient response to chemotherapy by measuring mitochondrial function and cancer cell apoptotic potential
eutropics.com →- Grants
- $3.0M
- 3 awards
- Sector median: 1
- Raised
- $350K
- 2 Form D · Jan 2024
- 33 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 39
- 10 granted · 29 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20172018201920202021202220232024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · Commercializing Praedicare Dx TM platform for guiding cancer treatments | $998,807 | |
| Federal grant | Department of Health and Human Services · Phase II · Commercializing Praedicare Dx TM platform for guiding cancer treatments | $991,179 | |
| Federal grant | Department of Health and Human Services · Phase II · Commercializing Praedicare Dx TM platform for guiding cancer treatments | $1,000,000 | |
| Private capital raised | Form D · SEC | $350,000 | |
| Private capital raised | Form D · SEC | $350,000 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1447 | Obstetrx, Inc. | — | $1.1M |
| 1448 | Anuncia Medical, Inc. | — | $12M |
| 1449 | Oxford Biodynamics PLC | — | $5.0M |
| 1450 | EUTROPICS PHARMACEUTICALS, INC. | — | $350K |
| 1451 | CELLOGY, INC. | — | — |
| 1452 | SOSTOS LLC | — | — |
| 1453 | Cradle Genomics, Inc. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Michael CardoneDirector · Executive Officer
Patents
- Methods For Predicting Cancer Drug Responsivenessgranted
- Methods And Compositions Related To BCL2 And Bim Heterodimer Antibodiesapplication
- Method For Predicting Cancer Sensitivitygranted
- Methods For Determining Chemosensitivity And Chemotoxicitygranted
- Context Dependent Diagnostics Test For Guiding Cancer Treatmentapplication
- Methods For Predicting Cancer Drug Responsivenessapplication
- Context Dependent Diagnostics Test For Guiding Cancer Treatmentgranted
- Methods And Compositions Useful For Treating Diseases Involving BCL-2 Family Proteins With Quinoline Derivativesgranted
- Method For Predicting Cancer Sensitivitygranted
- Methods For Determining Chemosensitivity And Chemotoxicitygranted
- Methods And Compositions Useful For Treating Diseases Involving BCL-2 Family Proteins With Isoquinoline And Quinoline Derivativesgranted
- Differential BH3 Mitochondrial Profilingapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.